Oesophageal carcinoma, The Lancet, vol.381, issue.9864, pp.400-412, 2013. ,
DOI : 10.1016/S0140-6736(12)60643-6
Epidemiology of esophageal cancer, World Journal of Gastroenterology, vol.19, issue.34, pp.5598-606, 2013. ,
DOI : 10.3748/wjg.v19.i34.5598
Esophageal Cancer. New Engl, J. Med, pp.2241-52, 2003. ,
Chemoradiation Followed by Surgery Compared With Chemoradiation Alone in Squamous Cancer of the Esophagus: FFCD 9102, Journal of Clinical Oncology, vol.25, issue.10, 2007. ,
DOI : 10.1200/JCO.2005.04.7118
URL : https://hal.archives-ouvertes.fr/hal-00363743
F-Fluorodeoxyglucose Positron Emission Tomography in Esophageal Cancer, Journal of Clinical Oncology, vol.22, issue.18, pp.3805-3817, 2004. ,
DOI : 10.1200/JCO.2004.01.083
Staging investigations for oesophageal cancer: a meta-analysis, British Journal of Cancer, vol.89, issue.3, pp.547-57, 2008. ,
DOI : 10.1136/gut.32.1.16
FDG-PET and the Response of Esophageal Cancer to Induction Therapy: Results of a Prospective Trial, Journal of Clinical Oncology, vol.21, issue.3, pp.428-460, 2003. ,
DOI : 10.1200/JCO.2003.04.013
FDG-PET parameters as prognostic factor in esophageal cancer patients: a review ,
Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours, European Journal of Nuclear Medicine and Molecular Imaging, vol.23, issue.5 Suppl, pp.290-301, 2013. ,
DOI : 10.1007/s00259-012-2280-z
18F-fluorodeoxyglucose positron emission tomography after definitive chemoradiotherapy in patients with oesophageal carcinoma, Digestive and Liver Disease, vol.44, issue.10, pp.875-884, 2012. ,
DOI : 10.1016/j.dld.2012.04.017
URL : https://hal.archives-ouvertes.fr/hal-00942163
Apport de la TEP au diagnostic, ??valuation th??rapeutique et suivi du cancer de l?????sophage, Cancer/Radioth??rapie, vol.12, issue.6-7, pp.633-642, 2008. ,
DOI : 10.1016/j.canrad.2008.07.001
Prediction of Tumor Response to Neoadjuvant Therapy in Patients with Esophageal Cancer with Methods : Results : Conclusion : Radiology, pp.707-724, 2010. ,
The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3) Eur ,
Time Course of Tumor Metabolic Activity During Chemoradiotherapy of Esophageal Squamous Cell Carcinoma and Response to Treatment, Journal of Clinical Oncology, vol.22, issue.5, pp.900-908, 2004. ,
DOI : 10.1200/JCO.2004.07.122
PET/CT-based metabolic tumour volume for response prediction of neoadjuvant chemoradiotherapy in oesophageal carcinoma, European Journal of Nuclear Medicine and Molecular Imaging, vol.53, issue.10, 2013. ,
DOI : 10.1007/s00259-013-2468-x
Prognostic Value of Metabolic Tumor Volume Measured by 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Esophageal Carcinoma, Annals of Surgical Oncology, vol.34, issue.1, pp.115-137, 2010. ,
DOI : 10.1245/s10434-009-0719-7
FDG-PET/CT Tumor Segmentation-Derived Indices of Metabolic Activity to Assess Response to Neoadjuvant Therapy and Progression-Free Survival in Esophageal Cancer, American Journal of Clinical Oncology, vol.30, issue.4, pp.377-88, 2007. ,
DOI : 10.1097/COC.0b013e31803993f8
Baseline 18F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancer, European Journal of Nuclear Medicine and Molecular Imaging, vol.17, issue.1, pp.1595-606, 2011. ,
DOI : 10.1007/s00259-011-1834-9
URL : https://hal.archives-ouvertes.fr/inserm-00595534
Oesophageal squamous cell carcinoma: relationship between fluorine-18 fludeoxyglucose positron emission tomography CT maximum standardised uptake value, metabolic tumour volume, and tumour, node and metastasis classification, The British Journal of Radiology, vol.85, issue.1016, pp.383-390, 2012. ,
DOI : 10.1259/bjr/79854022
Esophageal carcinoma advances in treatment results for locally advanced disease: review, Annals of Oncology, vol.23, issue.5, pp.1095-103, 2012. ,
DOI : 10.1093/annonc/mdr433
FDG-PET-positive tissue: application to the comparison of three thresholding models, Physics in Medicine and Biology, vol.54, issue.22, pp.6901-6917, 2009. ,
DOI : 10.1088/0031-9155/54/22/010
URL : https://hal.archives-ouvertes.fr/inserm-00467195
Metabolic Tumor Width Parameters as Determined on PET/CT Predict Disease-free Survival and Treatment Response in Squamous Cell Carcinoma of the Esophagus, Molecular Imaging and Biology, vol.35, issue.1, pp.54-60, 2009. ,
DOI : 10.1007/s11307-008-0169-9
The analysis of factors affecting the threshold on repeated 18F-FDG-PET/CT investigations measured by the PERCIST protocol in patients with esophageal carcinoma, Nuclear Medicine Communications, vol.33, issue.11, pp.1188-94, 2012. ,
DOI : 10.1097/MNM.0b013e3283573d0d
Tumor Volume as Outcome Determinant in Patients Treated With Chemoradiation for Locally Advanced Esophageal Cancer, American Journal of Clinical Oncology, vol.29, issue.6, pp.583-590, 2006. ,
DOI : 10.1097/01.coc.0000242346.25229.48
Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology, European Journal of Nuclear Medicine and Molecular Imaging, vol.51, issue.9, pp.1191-202, 2011. ,
DOI : 10.1007/s00259-011-1755-7
URL : https://hal.archives-ouvertes.fr/inserm-00574267
Predictive Value of 18-Fluoro-Deoxy-Glucose-Positron Emission Tomography (18F-FDG-PET) in the Identification of Responders to Chemoradiation Therapy for the Treatment of Locally Advanced Esophageal Cancer, Annals of Surgery, vol.243, issue.4, pp.472-480, 2006. ,
DOI : 10.1097/01.sla.0000208430.07050.61
Comparisons of Sixth and Seventh Edition of the American Joint Cancer Committee Staging Systems for Esophageal Cancer, Annals of Surgical Oncology, vol.29, issue.2, 2013. ,
DOI : 10.1245/s10434-013-3335-5
Prognostische Bedeutung von Lymphknoten-Charakteristika f??r das ??berleben beim Plattenepithelkarzinom des ??sophagus, Wiener klinische Wochenschrift, vol.19, issue.6, pp.26-33, 2013. ,
DOI : 10.1007/s00508-012-0310-2
Do Tumor Grade and Location Affect Survival in Esophageal Squamous Cell Carcinoma? Survival Analysis of 302 Cases of pT3N0M0 Esophageal Squamous Cell Carcinoma, Annals of Surgical Oncology, vol.29, issue.2, pp.580-585, 2013. ,
DOI : 10.1245/s10434-012-2656-0
The prognostic effect of ethnicity for gastric and esophageal cancer: the population-based experience in British Columbia, Canada, BMC Cancer, vol.10, issue.1, p.164, 2011. ,
DOI : 10.1200/JCO.2003.11.054
Prognostic factors for the survival of patients with esophageal carcinoma in the U.S., Cancer, vol.72, issue.7, pp.1434-1477, 2002. ,
DOI : 10.1002/cncr.10868
Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures, European Journal of Nuclear Medicine and Molecular Imaging, vol.53, issue.Suppl 1, pp.1507-1522, 2013. ,
DOI : 10.1007/s00259-013-2465-0